Therefore, it will be important, in future studies, to evaluate the consequence of IRE1alpha/XBP1 axis inhibition on the cross-talk between PEL cells and cells of the tumor environment or whether IRE-XBP1 signaling inhibition may interfere with HIF1α. The gene discussed is HIF1A; the disease is neoplasm.